CLINICAL_TRIALS trial_result · 2023-07-25

Clinical Trial Update: Trial to Investigate the Effect of ESN364 in Early Postmenopausal Women Suffering From Hot Flashes [Phase 2]

A Phase 2 trial evaluating ESN364 in early postmenopausal women with hot flashes has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ogeda S.A. | Conditions: Hot Flashes | Phase 2 | Status: COMPLETED | Results posted: 2023-07-25